Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Robert Lyle

Concepts (109)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ductus Arteriosus, Patent
2
2019
36
0.330
Why?
DNA
1
2010
597
0.280
Why?
Intensive Care Units, Neonatal
2
2018
120
0.280
Why?
Asthma
1
2010
302
0.270
Why?
Infant, Premature
4
2019
341
0.220
Why?
Medicaid
2
2018
279
0.210
Why?
Disabled Children
2
2013
74
0.200
Why?
Infant, Newborn
7
2019
2931
0.180
Why?
Hospitalization
2
2017
714
0.170
Why?
Persistent Fetal Circulation Syndrome
1
2019
10
0.170
Why?
Health Care Costs
2
2018
186
0.160
Why?
Chronic Disease
3
2011
625
0.160
Why?
Infant, Low Birth Weight
1
2018
77
0.160
Why?
Child, Preschool
7
2018
4220
0.150
Why?
Continuity of Patient Care
1
2018
63
0.150
Why?
Immunologic Deficiency Syndromes
1
2016
21
0.140
Why?
Clinical Protocols
1
2017
120
0.140
Why?
Hypoglycemia
1
2016
62
0.140
Why?
Infant, Premature, Diseases
1
2017
95
0.140
Why?
DNA Copy Number Variations
2
2016
111
0.130
Why?
Developmental Disabilities
1
2016
128
0.130
Why?
Child
8
2018
7483
0.130
Why?
Hospitals, Pediatric
3
2013
270
0.120
Why?
Comprehensive Health Care
1
2013
8
0.110
Why?
Emergency Service, Hospital
1
2018
546
0.110
Why?
Infant
6
2018
3903
0.110
Why?
Blood Cells
1
2012
53
0.100
Why?
Genome, Human
1
2012
127
0.100
Why?
Child, Exceptional
1
2011
6
0.100
Why?
Cost Savings
1
2011
64
0.090
Why?
Parents
1
2013
348
0.090
Why?
Fetal Blood
1
2010
70
0.090
Why?
Follow-Up Studies
2
2018
2359
0.090
Why?
Gene Expression Regulation, Developmental
1
2010
150
0.090
Why?
Genetic Association Studies
1
2010
132
0.090
Why?
Longitudinal Studies
3
2018
738
0.090
Why?
Ambulatory Care
1
2011
237
0.080
Why?
Patient Care Team
1
2011
272
0.080
Why?
Outpatient Clinics, Hospital
1
2009
42
0.080
Why?
Health Knowledge, Attitudes, Practice
1
2013
536
0.080
Why?
Genotype
1
2010
612
0.080
Why?
Time Factors
2
2018
3223
0.080
Why?
Humans
13
2022
54581
0.080
Why?
Child Health Services
1
2009
96
0.080
Why?
Home Care Services
1
2009
79
0.080
Why?
Female
8
2018
28520
0.070
Why?
Polymorphism, Single Nucleotide
1
2010
549
0.070
Why?
Male
7
2018
27656
0.070
Why?
DNA Methylation
1
2010
584
0.070
Why?
Cohort Studies
3
2018
1545
0.060
Why?
Patient Discharge
2
2018
352
0.060
Why?
Prospective Studies
1
2010
2534
0.060
Why?
Embryonic Stem Cells
1
2022
17
0.050
Why?
Cell Differentiation
2
2022
721
0.050
Why?
Age Factors
2
2018
1198
0.050
Why?
Peptide Hydrolases
1
2002
68
0.050
Why?
Acetylcysteine
1
2002
119
0.050
Why?
Phosphoproteins
1
2002
110
0.050
Why?
Adolescent
3
2018
6941
0.050
Why?
Adipocytes
1
2002
128
0.050
Why?
Proteasome Endopeptidase Complex
1
2002
133
0.050
Why?
Arkansas
3
2013
2172
0.050
Why?
Cell Survival
1
2022
676
0.050
Why?
Time
1
2018
36
0.040
Why?
Ibuprofen
1
2018
26
0.040
Why?
Indomethacin
1
2018
41
0.040
Why?
Proteins
1
2002
378
0.040
Why?
Birth Weight
1
2019
110
0.040
Why?
Cyclooxygenase Inhibitors
1
2018
43
0.040
Why?
Neurons
1
2022
521
0.040
Why?
United States
3
2018
5292
0.040
Why?
Infant, Newborn, Diseases
1
2016
65
0.030
Why?
Patient Readmission
1
2018
235
0.030
Why?
Incidence
1
2018
1090
0.030
Why?
Logistic Models
1
2018
990
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2016
197
0.030
Why?
Databases, Factual
1
2018
697
0.030
Why?
Length of Stay
1
2018
685
0.030
Why?
Young Adult
2
2016
4322
0.030
Why?
Genomics
1
2016
310
0.030
Why?
Blood Glucose
1
2016
487
0.030
Why?
Risk Assessment
1
2018
1360
0.030
Why?
Health Care Surveys
1
2013
192
0.030
Why?
Twins, Monozygotic
1
2012
17
0.030
Why?
Individuality
1
2012
31
0.030
Why?
Patient-Centered Care
1
2013
140
0.020
Why?
Myelodysplastic Syndromes
1
2012
82
0.020
Why?
Cerebral Palsy
1
2010
42
0.020
Why?
Aged
2
2016
10043
0.020
Why?
Cost-Benefit Analysis
1
2011
301
0.020
Why?
Bronchopulmonary Dysplasia
1
2010
71
0.020
Why?
Multivariate Analysis
1
2011
641
0.020
Why?
Middle Aged
2
2016
13036
0.020
Why?
Adult
2
2016
14239
0.020
Why?
Program Evaluation
1
2009
384
0.020
Why?
Quality of Life
1
2013
935
0.020
Why?
Rural Population
1
2011
609
0.020
Why?
Mutation
1
2012
1420
0.020
Why?
Retrospective Studies
1
2018
6520
0.020
Why?
Aged, 80 and over
1
2012
3420
0.010
Why?
Leupeptins
1
2002
8
0.010
Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
Why?
Cysteine Proteinase Inhibitors
1
2002
29
0.010
Why?
Treatment Outcome
1
2013
5594
0.010
Why?
Calpain
1
2002
29
0.010
Why?
Kinetics
1
2002
705
0.010
Why?
Nuclear Proteins
1
2002
264
0.010
Why?
Cell Line
1
2002
1139
0.010
Why?
Animals
1
2002
14777
0.000
Why?
Lyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description